53 results
S-3ASR
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
, funding research and development, clinical trials, vendor payables, potential regulatory submissions, hiring additional personnel and capital … preparation and potential launch, hiring additional personnel and capital expenditures. We may also use a portion of the net proceeds to in-license, acquire
424B5
IMVT
Immunovant Inc
29 Sep 23
Prospectus supplement for primary offering
4:48pm
and potential launch, hiring additional personnel and capital expenditures. We may also use a portion of the net proceeds to in-license, acquire … , vendor payables, potential regulatory submissions, commercial preparation and potential launch, hiring additional personnel and capital expenditures
424B5
omdpx10w
26 Sep 23
Prospectus supplement for primary offering
5:28pm
424B5
dms8u0mlhtkhpf
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-10.1
bt9qn14hd zak53
15 Sep 21
Immunovant Appoints Renee Barnett as Chief Financial Officer
7:23am